Aiman Kawas, - Pharmacist in Dearborn Heights, MI

Aiman Kawas, is a Pharmacist based in Dearborn Heights, Michigan. Aiman Kawas is licensed to practice in Michigan (license number 5302028635) and his current practice location is 27391 Terrell St, Dearborn Heights, Michigan. He can be reached at his office (for appointments etc.) via phone at (313) 657-1630.

NPI number for Aiman Kawas is 1013175256 and his current mailing address is 27391 Terrell St, Dearborn Heights, Michigan. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1013175256.

Contact Information

Aiman Kawas,
27391 Terrell St,
Dearborn Heights, MI 48127-2866
(313) 657-1630
Not Available

Healthcare Provider's Profile

Full NameAiman Kawas
GenderMale
SpecialityPharmacist
Location27391 Terrell St, Dearborn Heights, Michigan
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1013175256
  • Provider Enumeration Date: 05/23/2008
  • Last Update Date: 05/23/2008

Medical Identifiers

Medical identifiers for Aiman Kawas such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013175256NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist 5302028635 (Michigan)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Aiman Kawas is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Aiman Kawas,
27391 Terrell St,
Dearborn Heights, MI 48127-2866

Ph: () -
Aiman Kawas,
27391 Terrell St,
Dearborn Heights, MI 48127-2866

Ph: (313) 657-1630

News Archive

Nymox Pharmaceutical announces new positive results from long term outcome study of NX-1207 for BPH

Nymox Pharmaceutical Corporation today announced new 2010 positive results from a long term outcome study of NX-1207 for benign prostatic hyperplasia (BPH). The study evaluated symptomatic progress of U.S. patients involved in the Company's NX02-0012 and NX02-0013 Phase 1-2 studies of NX-1207 initially undertaken in 2003. Patients treated with NX-1207 were followed-up on an unselected and as available basis and assessed for symptomatic improvement, treatment outcomes, and durability of efficacy 6 ½ years after a single treatment with NX-1207.

New technology developed to more quickly detect and trace foodborne disease

University of Massachusetts Amherst food scientist Matthew Moore has received two grants from the USDA to apply new technology in an effort to more quickly detect and trace foodborne disease caused by noroviruses and bacteria.

Economist Stuart Butler: Give states maximum flexibility under health reform

In this wide-ranging interview with Kaiser Health News, the Heritage Foundation's Stuart Butler talks about the proposal to have the federal Office of Personnel Management (OPM) have a role in expanding insurance coverage to more Americans; the increasingly heated debate over the roles of the federal government and the states in implementing any legislation: and the merits - or demerits - of an individual mandate.

How SARS-CoV-2 vaccination symptoms differ from early COVID-19 symptoms

A new study published on the preprint server medRxiv* presents an analysis of the differences between recorded vaccination side effects vs. early COVID-19 symptoms. The researchers focused on four vaccines, namely, Pfizer-BioNTech (PB) mRNA (BNT162b2) vaccine, based on messenger ribonucleic acid encoding the viral spike protein; the Moderna mRNA (mRNA-1273) vaccine; the Oxford-AstraZeneca (O-AZ) adenovirus-vectored vaccine; and the Janssen adenovirus-vectored Ad26.COV2.S).

Read more News

› Verified 5 days ago


Pharmacist in Dearborn Heights, MI

Mrs. Nabiha M Salameh, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1301 Whitefield St, Dearborn Heights, MI 48127
Phone: 313-274-8510    
Mrs. Sarah Jane Shimazaki, DPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 5688 N Telegraph Rd, Dearborn Heights, MI 48127
Phone: 313-565-9357    Fax: 313-565-8457
Ali Chammout,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 27151 Wilson Dr, Dearborn Heights, MI 48127
Phone: 313-404-9584    
Hassan Khalil Nasser, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 26095 Timber Trl, Dearborn Heights, MI 48127
Phone: 313-574-2703    
Mona Hammoud, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 25700 Ford Rd, Dearborn Heights, MI 48127
Phone: 313-359-9640    
Mohamad Ibrahim Mustapha,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1780 Whitefield St, Dearborn Heights, MI 48127
Phone: 313-632-6054    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.